Skip to main content
Premium Trial:

Request an Annual Quote

Chicago-Based Proteomics/Bioinformatics Project Receives $1.95 Million in Funding

NEW YORK, Jan. 10 (GenomeWeb News) - The Searle Funds at The Chicago Community Trust have awarded $1.5 million to the Chicago Biomedical Consortium for a proteomics/bioinformatics demonstration project, the University of Illinois at Chicago, the University of Chicago, and Northwestern University said today.

 

The universities have also agreed to contribute an additional $150,000 each to the project.

 

According to the universities, the proteomics/bioinformatics project is the CBC's first initiative, and will join "experimentalists, instrumentalists and informaticians to apply new technology and new analytical techniques to addressing the basic questions of proteomics."

 

Researchers working under the project will have access to a Fourier transform mass spectrometer, the universities noted. The FTMS is expected to be in place by the summer, but before then research teams and computational resources will be established to analyze the large amounts of data expected to come out of the proteomics/bioinformatics effort.

 

The universities noted that the FTMS would be available to all researchers throughout the Chicago area, not just those at the UIC, the University of Chicago, and NorthwesternUniversity.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.